Atlas Trials

Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia

Clinical trial NCT01726335 · COMPLETED

Trial details

NCT number
NCT01726335
Sponsor
Janssen-Cilag Ltd.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2006-01-01
Primary completion
2008-03-01
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.